https://aladiagnostics.com/2022/11/01/la-prueba-de-ala-diagnostics-obtiene-125-millones-de-euros-de-financiacion-para-el-desarrollo-y-comercializacion-del-primer-biomarcador-para-el-diagnostico-de-la-esclerosis-multiple-en-sangre/2022-11-01T10:00:00+01:00https://aladiagnostics.com/2023/01/30/ala-diagnostics-recibe-una-subvencion-europea-de-14-millones-de-euros-del-programa-eic-accelerator-para-el-desarrollo-de-su-sistema-de-diagnostico-temprano-de-la-esclerosis-multiple/2023-01-30T10:00:00+01:00https://aladiagnostics.com/2023/12/01/ala-diagnostics-crece-en-madrid-con-un-nuevo-laboratorio-tras-dar-entrada-a-beable-capital/2023-12-01T07:51:00+01:00https://aladiagnostics.com/2023/11/06/beable-capital-inyecta-un-millon-en-la-biotech-ala-diagnostics/2023-11-06T08:21:00+01:00https://aladiagnostics.com/2023/06/22/ala-diagnostics-levanta-11-millones-y-da-entrada-en-su-capital-a-beable-capital/2023-06-22T09:38:00+02:00https://aladiagnostics.com/2023/03/31/ala-diagnostics-en-hola-andalucia/2023-03-31T11:02:00+02:00https://aladiagnostics.com/2023/02/02/ala-diagnostics-prepara-su-aterrizaje-en-eeuu-y-capta-14-millones-en-ayudas-europeas/2023-02-02T12:09:00+01:00https://aladiagnostics.com/2021/03/30/una-biotecnologica-espanola-disena-el-primer-test-de-diagnostico-temprano-de-la-esclerosis-multiple-en-sangre/2021-03-30T15:14:00+02:00https://aladiagnostics.com/2021/04/21/dr-oscar-fernandez-existe-un-numero-importante-de-pacientes-con-un-diagnostico-erroneo-de-esclerosis-multiple/2021-04-21T15:20:00+02:00https://aladiagnostics.com/2022/09/20/acto-de-celebracion-del-15-aniversario-de-fundacion-gaem/2022-09-20T15:27:00+02:00https://aladiagnostics.com/2020/05/15/ala-diagnostics-se-suma-a-la-aceleradora-gaem/2020-05-15T15:32:00+02:00https://aladiagnostics.com/2025/07/07/jose-ramon-montero/2025-07-30T15:32:08+02:00https://aladiagnostics.com/2025/07/07/dr-oscar-fernandez/2025-07-30T15:32:40+02:00https://aladiagnostics.com/2025/07/07/dr-jose-pavia/2025-07-30T14:05:45+02:00https://aladiagnostics.com/2025/07/07/dra-susana-frago/2025-07-30T15:34:35+02:00https://aladiagnostics.com/2025/07/07/amparo-fornes/2025-07-30T15:35:04+02:00https://aladiagnostics.com/2025/07/07/beatriz-tames/2025-07-24T13:20:34+02:00https://aladiagnostics.com/2025/07/07/gema-escalera/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/07/sonia-sanchez/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/07/virginia-moreno/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/07/dra-itziar-ochotorena/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/07/laura-obiols/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/07/gustavo-fuster/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/08/el-proyecto-de-ala-diagnostics-recibe-125-millones-para-desarrollar-y-comercializar-el-primer-biomarcador-para-el-diagnostico-de-la-esclerosis-multiple-en-sangre/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/08/ala-diagnostics-recibe-una-subvencion-europea-de-mas-de-14-millones-de-euros-para-el-desarrollo-de-su-sistema-de-diagnostico-temprano-de-la-esclerosis-multiple-en-sangre/2025-07-28T15:42:02+02:00https://aladiagnostics.com/2025/07/30/universidad-de-malaga/2025-07-30T13:36:58+02:00https://aladiagnostics.com/2025/07/30/hospital-universitario-ramon-y-cajal/2025-07-30T13:37:14+02:00https://aladiagnostics.com/2025/07/30/hospital-regional-universitario-de-malaga/2025-07-30T13:38:41+02:00https://aladiagnostics.com/2025/07/30/genscript/2025-07-30T13:40:51+02:00https://aladiagnostics.com/2025/07/30/episkey-medical-consulting/2025-07-30T13:41:02+02:00https://aladiagnostics.com/2025/07/30/evidenze/2025-07-30T13:42:12+02:00https://aladiagnostics.com/2025/07/30/hoffmann-eitle/2025-07-30T13:43:33+02:00https://aladiagnostics.com/2025/07/30/thermofisher-scientific/2025-07-30T13:44:43+02:00https://aladiagnostics.com/2025/07/30/consejeria-de-salud-de-andalucia/2025-07-30T13:45:47+02:00https://aladiagnostics.com/2025/07/30/ala-diagnostics-es-premiada-como-top-pathologies-in-vitro-diagnostic-kits-development-company-in-europe-2025/2025-07-30T17:03:03+02:00https://aladiagnostics.com/2025/10/21/ala-diagnostics-avanza-en-el-desarrollo-del-primer-kit-diagnostico-in-vitro-para-la-esclerosis-multiple-basado-en-un-analisis-de-sangre/2025-10-29T13:40:22+01:00https://aladiagnostics.com/2025/10/30/entrevista-ala-diagnostics-en-la-fundacion-gaem/2025-10-30T13:35:55+01:00https://aladiagnostics.com/2025/11/04/entrevista-ala-diagnostics-en-radio-marca/2025-11-04T16:35:15+01:00